CoTherix, Inc. operates as a development stage company that engages in biopharmaceutical operations.
Business Model:
Revenue: $0
Employees: 51-200
Cotherix was acquired by
Actelion Pharmaceuticals.
The acquisition happend on 2006-11-20.
Details of the transaction were not public
Address:
City: San Francisco
State: California
Zip:
Country: United States
Cotherix is a biopharmaceutical company focused on licensing, developing and commercializing therapeutic products for the treatment of cardiopulmonary and other chronic diseases. Ventavis, our lead product candidate, is an inhaled formulation of iloprost.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/15/2004
Ticker Symbol:
CTRX
IPO Price:
$6/share
Amount Raised:
$30M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2001 | Venture Round | 1 | - |
Sofinnova Investments Sofinnova Investments |
10/2003 | Series C | 8 | $55M |
Alta Partners Frazier Healthcare Partners MPM Capital Sofinnova Investments Sofinnova Partners Spray Venture Partners Thomas Weisel Venture Partners Vivo Capital Alta Partners Frazier Healthcare Partners MPM Capital Sofinnova Investments Sofinnova Partners Spray Venture Partners Thomas Weisel Venture Partners Vivo Capital |
1/2001 | Venture Round | 1 | - |
Sofinnova Investments Sofinnova Investments |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|